BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) announced today that total revenues increased 9% to a record high $543 million during the second quarter ended June 30, 2007, compared to $500 million in the second quarter of 2006. Reported net income equaled $65 million and diluted income per share equaled $0.26 during the second quarter of 2007, compared to net earnings of $111 million and diluted earnings per share of $0.46 in the second quarter of the prior year. Excluding special items, net earnings equaled $117 million and diluted earnings per share equaled $0.48 during the second quarter ended June 30, 2007, compared to net earnings of $112 million and diluted earnings per share of $0.46 in the second quarter of 2006.
